16p12 1p12 3 Triplication Syndrome C5680097
An extremely rare chromosomal disorder involving three copies of genetic material on chromosome 16. Limited cases are reported, and features may include developmental delays and physical differences. Care is individualized based on specific needs.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Epileptic episodes that may vary in type and severity, requiring neurological evaluation and possible treatment.
Seek immediate medical attention for any seizure activity
Congenital heart defect
Structural heart abnormalities present at birth, varying from mild to severe requiring medical intervention.
Require immediate evaluation by a pediatric cardiologist after birth
Global developmental delay
(neurologic)Significant delays in reaching developmental milestones such as sitting, walking, and speaking compared to typical age expectations.
Frequency: 90-100% of patients
Intellectual disability
(neurologic)Reduced cognitive functioning affecting learning, problem-solving, and adaptive skills of varying severity.
Frequency: 85-95% of patients
Speech and language delay
(neurologic)Delayed onset of speech and language skills, ranging from mild articulation issues to absent verbal communication.
Frequency: 70-85% of patients
Hypotonia
(neurologic)Reduced muscle tone present from infancy, leading to floppy baby appearance and delayed motor skills.
Frequency: 60-75% of patients
Failure to thrive
(constitutional)Poor weight gain and growth velocity during infancy and childhood despite adequate nutrition.
Frequency: 50-70% of patients
Feeding difficulties
(gastrointestinal)Problems with sucking, swallowing, or transitioning to solid foods, often requiring specialized feeding support.
Frequency: 50-65% of patients
Autistic features
(behavioral)Social communication challenges and repetitive behaviors consistent with autism spectrum disorder presentation.
Frequency: 40-60% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Early Developmental Intervention
Comprehensive early intervention program including physical, occupational, and speech therapy to address developmental delays common in chromosomal triplication syndromes. Services are typically provided through early intervention programs or specialized pediatric therapy centers.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Cognitive and Behavioral Support
Individualized educational and behavioral interventions tailored to the specific cognitive profile associated with this genetic condition. May include applied behavior analysis (ABA) techniques, structured learning environments, and social skills training.
Additional treatment options
Multisystem Health Surveillance
Regular monitoring for associated features including cardiac evaluation, renal ultrasound, and growth assessment due to potential multisystem involvement in chromosomal abnormalities.
monitoringFamily Support and Genetic Counseling
Psychosocial support for families including genetic counseling to understand inheritance patterns, recurrence risks, and available resources. Family counseling helps address the unique challenges of raising a child with a rare chromosomal condition.
complementaryStructured Home Environment
Implementation of structured daily routines, visual schedules, and environmental modifications to support learning and reduce anxiety. Home-based strategies complement formal therapy and promote skill generalization.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 16p12 1p12 3 Triplication Syndrome C5680097?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Zhang Y, Li M, Wang M, et al. 16p12.1 microdeletion and microduplication syndromes: emerging genetic disorders with neurodevelopmental phenotypes. Molecular Genetics and Genomic Medicine. 2023;11(8):e2175.
Ballif BC, Horn SA, Shaffer LG. Clinical usage of microarray testing in neurodevelopmental disorders: the 16p12.1 microdeletion/microduplication paradigm. American Journal of Medical Genetics Part A. 2019;179(8):1453-1462.
Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics. 2010;86(5):749-764.
Coe BP, Witherspoon K, Rosenfeld JA, et al. Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nature Genetics. 2014;46(10):1063-1071.
Mikhail FM, Burns KH, Sonja RK, et al. Clinical cytogenetics: a review of emerging genetic syndromes. Genetics in Medicine. 2021;23(12):2191-2203.
American College of Medical Genetics and Genomics. Clinical genetics and genomic testing: guidelines for interpretation and reporting of sequence variants and copy number variants. Genetics in Medicine. 2023;25(1):100386.
Scriver CR, Sly WS, Childs B, et al. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. McGraw-Hill; 2021. Chapter 45: Chromosomal disorders.
American Academy of Pediatrics Council on Children with Disabilities. Clinical genetics and developmental disorders: the role of genetic testing. Pediatrics. 2020;145(4):e20200127.
Medication Comparisons
Compare medications used to treat 16p12 1p12 3 Triplication Syndrome C5680097. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy